Rare diseases
Investigational molecules
Locations
17 Place Des Reflets, 92400 Courbevoie, France
Research activity is centred on the long-term effects of repeated exposure to gadolinium-based contrast agents in neurologically normal adults, with attention to changes in motor function and cognitive function over time.
The trial landscape includes comparison with a matched non-exposed control population to evaluate functional changes associated with repeated contrast-enhanced imaging.
Iqvia Rds France runs clinical trials in conditions such as Cognitive disorder, among others.
Clinical trials run by this sponsor – those enrolling participants first.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
